Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Golden Grand Starts China Trial of Minimally Invasive GERD Device

publication date: Feb 11, 2016
Shanghai Golden Grand-Medical Instruments, a unit of Sinopharm, will begin a China trial of a minimally invasive device developed by Medigus of Israel to treat GERD (gastroesophageal reflux disease). The MUSE system includes a very small Medigus camera and an ultrasonic surgical endostapler that staples the upper part of the stomach to the lower esophageal sphincter in a fundoplication procedure. The MUSE system is already approved for use in the US and Europe. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital